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The first genetic polymorphism to be described
in man was the ABO blood group system. This system proved to be present as a membrane antigen of
the cells of almost all organs of the body. In this it not
only simulates histocompatibility antigens but also
helps to determine ABO compatibility between organ
recipients and their donors . The presence of the A BH
and H L-A antigens in tissues and their stability on
storage allows typing mummified bodies despite the
passage of thousands of years.
The possibility that the ABO blood groups
might be associated with diseases and subject to natural selection was considered soon after their discovery
by Landsteiner, while the Herszfelds were the first to
use the ABO blood groups as markers for studying
ethnic differences as an aid to the study of evolution.
Since retrospective paleoserologic studies of human
populations using their remains are possible only
when A BO groups are present on tissue cells of the
organs, the discovery of the HL-A antigens was a
welcome additional means of studies in mummies.
This is mainly because the HL-A system proved to
be the most highly polymorphic antigen system in
man-a most helpful characteristic in studies of natural selection and evolution in human populations.
The paleoserologic studies reported here have
been carried out to determine the frequency and distribution of the ABO and HL-A antigens in mummiSupported by a grant from the National Geographic
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fied bodies belonging to various c ultural groups. The
information is useful in the study of evolution of the
American Indians.

Materials and Methods.

Mummified Tissue Samples. One hundred and
eleven samples consisting of fragments of muscles
from various parts of the bodies of mummies, but
mainly from the psoas area, were tested; the mummies were obtained from known cemeteries which
were excavated scientifically by archeologists a nd
were dated by 14 C in 20 cases. The mummies were
placed in four groups: (a) the pre-Columbian, preCeramic, (b) the pre-Columbian , Ceramic, (c) Chilean Colonials, and (d) Peruvian Colonials; the preColumbian mummies were further divided into the
cultural groups: Paracas, Nazca, Huari, Inca, a nd
lea.
ABO GROUPING SERA AND CELLS
The standard agglutination-inhibition technique
was applied to determine the presence or absence of
the A and B antigens or both in the mummified
tissues. This has been previously described in detail. 1
HL-A TYPING
The lymphocytotoxicity-inhibition test was used
to type the mummies. The procedure employed by
Stastny8 was followed with some modifications.
The tests were performed on 109 of the samples
only . Insufficient material prevented typing two of
the tissues which belonged to the Ceramic group .
The tissues were typed for the following anti67
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gens: HL-Al, HL-A2, HL-A3, HL-A9, HL-All ,
W 19 and W28 ( of the first segregant series) and H LAS, HL-A7, HL-A8, HL-Al2, HL-Al3 , W5 , Wl4 ,
W 15 and W 17 (of the second segregant series) using
the corresponding a nti-sera.
Materials.
I. Beef Lung H eparin. Upjohn Company , 6130
N. Capital Street, N.W., Washington , D. C.
20011. #7969.
2. Barbital Buffer. Barbitone C. F. T . Diluent
Consolidated Laboratories, Inc., Chicago
Heights, Ill. 60411.
3. Tris-NH 4 Cl. Mix I part Tris Buffer (a) in
9 parts NH 4 CI (b).
a. Tris Buffer. #T-1503 Trisrna Base. Sigma
Chemical Company , P. 0 . Box 14508, St .
Louis, Mo. 63178 .
Use: 20.6 gm Tris/ 1000 cc distilled water.
Make up a flask 1/ 2 to 3/ 4 volume and
adjust pH with concentrated HCI to pH
7 .2 to 7.4 (starting pH will be about pH
11 .00). Do at room temperature. Transfer to volumetric flask and add distilled
water to desired volume .
b. Arnoniurn chloride. Use 0.83 gm NH 4 C II
100 cc distilled water.
4. a. Nylon. E. I. DuPont de Nemours Corn pany, Wilmington , Del. 19801. #67030
100% Nylon, staple, semi-dull, I to 1/ 2
inch length , 3 denier, type 200.
b. Dupanol. #241900, Dupanol RA. Liquid
1-356. E. I. DuPont de Nemours Cornpany , P. 0 . Box 1909, Charlotte, N. C .
28201.
Use: heat to 65 C to 70 C for 30 minutes
the following: 200 gm nylon, 4 liter water, and 20 cc dupanol. Stir continually
to prevent scorching. Rinse overnight in
tap water. Rinse thoroughly in distilled
water seven or eight times . Let air dry .
Comb and brush nylon to make fibers
separate. Weigh out 0.7 gm of combed
nylon and pack firmly into a small pasteur pipette. Cap with small rubber serum stopper.
c. Serum Stoppers. #8826 small rubber serum stopper. 5 X 9 mm EDP No. 8753 D22. Arthur H. Thomas Co., P.O. Box
779 , Philadelphia, Pa. 19105.
S. Trypan Blue. #TX 1580. General Scientific
Corp., P. 0. Box 2V, Richmond, Va. 23205 .

6.

7.

8.

9.
10.

11.

12 .

13 .

14.

15 .

Use: 1 grn / 100 ml distilled water, filtered =
1% stock solution . For daily use: dilute 3 ml
of I% stock solution with 7 ml of 2% EDT A
solution = 0.3% Trypan (occasional filteration of stock solution is needed) .
EDTA . # 1-8993 Disodiurn EDTA, Dihydrate VWR . P. 0 . Box 5195, Baltimore,
Md. 21203 .
Microplates (60 well plates) #3034 Falcon
Microtest plates. Arthur H. Thomas Co. ,
P. 0 . Box 779 , Philadelphia, Pa. 19105 .
Rabbit Complement. Grand Island Biological Co ., 3175 Staley Road, Grand Island,
N . Y. 14072.
Hamilton Syringe. Hamilton Co., Inc .,
Reno, Nev . 89504.
Hypaque . Hypaque, Sodium 50%, 3 ml
vials/ 25 / case. Winthrop Laboratories , Division of Sterling Drup, Inc ., New York,
N. Y. 10016.
Use: Hypaque 37.77% (with 0.1 % Na
Azide) . Make up 1000 ml in vol. flask. Take
755 .4 ml of 50% Hypaque and add I ml of
10% Na Azide. Top up to I liter with distilled water and mix thoroughly with magnetic stirrer.
Ficoll. #F-4375 Sigma Chemical Co., P. 0 .
Box 14508, St. Louis, Mo. 63178.
Use: Ficoll 9% (wt/vol) (with 0. 1% Na
Azide). Make up 3000 ml in vol. flasks . In
3000 ml flask put 270 gm Ficoll , 3 ml of
10% Na Azide, top up to 3 liters with disstilled water. Mix 1/ 2 hour with magnetic
stirrer.
Ficoll-Hypaque. Take 1 part Hypaque
37.77% (50 ml) with 3 parts Ficoll 9%
(1500 ml) . Mix one hour, check and adjust
density with hydrometer in a 250 ml graduated cylinder [optical density (O.D .) 1.077
to 1.079]. Store in dark bottles and refrigerate.
Membrane Dializer. Union Carbide Corporation, Food Products Division , 6733 West
65th Street, Chicago, Ill. 60638 .
Albumin Stock Solution. Stock No. 905-10.
Sigma Chemical Co., P. 0 . Box 14508, St.
Louis, Mo. 63178.
Falin Howerey Reagent (Folin-Ciocalteu).
Phenol 2N Solution. Fisher Scientific Co. ,
Chemical Manufacturing Division, Fair
Lawn , N. J. 07410.
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16. Dulbecco's Modified Eagle Modified. Cat
#H-16. Grand Island Biological Company,
Grand Island, N. Y. 14072 .
17 . Fetal Calf Serum. Grand Island Biological
Company , Grand Island, N. Y. 14072.
18. Solution A . 20 gm Na 2 C0 3 , 4.0 gm NaOH,
0.2 gm Na, K, tartrates, Dilute to 1 liter with
distilled water.
19. Solution B. 5 gm CuS0 4 , 5 H 2 0. Dilute 1
liter with distilled water.
20 . McCoy's Media. Grand Island Biological
Company, Grand Island, N. Y. 14072.
21. Panel of H L-A antigens prepared from donors at the Department of Surgery, Medical
College of Virginia, Richmond, Va.
22 . Anti-A and anti-B antiserum . Ortho Diagnostics, Ortho Pharmaceutical Corp., Raritan, N . J. 08869.
23. A and B red cells. Ortho Diagnostics, Orthc
Pharmaceutical Corp., Raritan, N. J. 08869.

Methods.
A . Cell Preparation.
1. Collect 10 cc of heparinized blood (25 units
hep/ ml blood) and pass it through a column
containing 0.5 to 1.0 gm of nylon into 10 ml
test tube. Then wash the column with barbital
buffer for maximum cell yield. Addition of
blood and washing are performed at room
tern perature.
2. Add an equal volume of barbital buffer and
mix, leaving enough room in tube for the
addition of 2_to 3 ml of Ficoll-Hypaque.
3. Layer cells over 2 to 3 ml of Ficoll-Hypaque.
4. Centrifuge at 2800 rpm for 15 to 20 minutes
using International Centrifuge.
5. With pipette remove lymphocytes from the
interface between the blood plasma and Ficoll-Hypaque, place in a 10 X 75 mm tube,
then wash cells with barbital buffer in a table
centrifuge spinning at 1400 rpm for six minutes.
6. Remove any red blood cells by adding warm
Tris-NH 4 Cl for five minutes. Spin cells at
I000 rpm for six minutes.
7. Reconstitute cells in McCoy's media with 5%
fetal calf serum to 2 million cells per ml and
store at 4 C. These cells are usable after a
maximum of four days of storage.
8. Test for cell viability by addition of a small
amount of 1% Trypan blue in 0.5 cc of cell
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suspension and look for blue cells (dead cells)
under the microscope. This procedure should
be done at the time of testing. If cell viability
is less than 90% to 95 %, discard the cell suspens10n .

B. Preparation of Mummy Extracts.
1. Press the mummy tissue through a stainless
steel sieve to obtain a fine powder.
2. Extract 2 gm of tissue powder twice in IO cc
saline with constant stirring at 37 C for 30
minutes.
3. Combine with two extracts and transfer them
to a dialysis membrane tube. Immerse the
membrane in 4 C distilled water overnight.
4. Use the dialized fluid, rich in protein , for
protein determination as follows :
a . Prepare standards (three each) containing
200 mg, 500 mg, and 1000 mg of Bovine
Serum Albumin.
b. Prepare two 0.1 ml aliquotes of each tissue
extract.
c. Bring volume of all tubes (standard and
samples) to 1.0 ml using distilled water.
d. Prepare solution C by mixing 50 parts of
solution A to I part of solution B (see
Materials for solutions A and B. ).
e. Add 5 ml of solution C to each tube.
f. Prepare Folio Howerey reagent (FolinCiocalteu) by adding 5 ml phenol reagent
2N solution to 7 ml distilled water.
g. Quickly add 0.6 ml of reagent to each tube
and shake vigorously.
h. Read at 420 mµ after 30 minutes, using
spectrophotometer.
1. Plot optical density (O.D.) vs concentration.
J. Blank contains I ml H 2 0, 5 ml solution C,
and 0.6 ml phenol reagent.
5. Each sample is then freeze-dried and dissolved in Dulbecco' s Modified Eagel Modified media .
C. Lymphocytotoxicity Inhibition Procedure.

1. Prepare a stock solution containing 24 mg
mummy protein / ml. This stock solution is
then used to prepare three working solutions, containing 6, 12, and 18 mg / ml respectively.
2. Titrate the antisera to be used using lymphocytes known to carry the corresponding
HL-A antigens to determine the endpoint
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3.

4.

5.

6.

7.

which is to be used as the wo rking anti serum.
Add I lambda of antiserum and I lambda
mummy tissue extract with protein concentrations of 18, 12, and 6 mg/ ml into separate wells of the Fa lcon with a Hamilton
syringe. T he mixture is incubated for one
hour at 22 C and then incubated overnight
at 4 C.
Next day, 1 lambda of cell suspension is
added to the above mixture and left to incubate at room temperature for 30 minutes.
(Use a thin wire to mix volumes not mixed in
the cell dispensing process).
The wells are then filled with barbital buffer,
using a thinly drawn Pasteur pipette, and
allowed to settle for ten minutes. Remove
buffer by flicking the plate with a quick motion o f the wrist.
Five lambda of rabbit complement which is
previously titered are then added to each
well. Make sure volumes are mixed . Plates
are incubated at room temperature for one
hour.
The complement must be removed by flicking the plates before sta ining the cell for
testing . Using a thinly drawn Pasteur pipette, fill each well with a drop of trypan
blue in EDT A. Let stand for ten minutes to
a llow cells to settle. Flick well once.

8. The wells are filled with barbital buffer and
allowed to settle ten minutes.
9. Add cover glass. Read.
10. The determinations are made by placing the
plate under an inverted phase microscope at
!SOX (!OX objectives, IS X ocular) and
judging the percentage of inhibition using
the following formula:

% inhibition = 100.
% cell killed in presence
of inhibitor

% cell killed in absence
of inhibitor

x 100

11. The following controls were added to each
test system, which consisted of target lymphocytes incubated with :
a . antiserum without mummy antigen.
b. with antiserum and mummy antigen, but
without complement.
c. with complement alone.
d. with mummy antigen alone.
All test and controls should be made in duplicate.
12. If percentage inhibition is low or absent, the
amou nt of protei n concentration should be
increased for a higher percentage inhibition
(protein concentration in mummy tissue extracts does not represent antigen concentra-

Table I
Percentage Distribution of ABO Antigens in 111 Pre-Columbian and Colonial Mummies and in Seven American Indian Tribal
Populations
N umber
Tested

Population s
M UM MIES (present study)
Pre-Co lum bian Pre-Ceram ic
Pre-Co lum b ia n Cera mic
Peruvian Co lon ia ls
Chilean Co lonials
AMERI C A N IND IANS6
Aymara
Warao
Quechua
l xil
Zuni
Pa pago
Pima
EUROPEAN CAUCAS IANS'

* Number

tested not given

0

A

B

AB

8
40
45
18

50
60.98
89
94.44

37.5
17.07
8.78
5.56

0
2.44
0
0

12.5
19.51
2.22
0

37

97
100
85.5
58.4
84.36
93.83
78.35
45

3
0
13.6
41.6
13.36
6.17
20.62
41

0
0
0.9
0
1.63
0
1.03
10

0
0
0
0
0.65
0
0
4

90
79
IOI

71
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Table 2
Number and Frequency in Percent( #/%) of HL-A Antigens Detected in Four Groups of Mummies
Number/ Percent o f H L-A Antigens Detected
Number
Tested

Group

0

2

3

4

PR E-COLOM BI AN
Pre-Ceramic
Ceramic

8
38

0/ 0
12/ 3 1.6

1/ 12.5
8/ 2 1

2/25
14/ 36.8

3/ 37.5
3/ 7.9

2/ 25
1/ 2.7

CO LONI A L
Chilea n
Peruvian

18
45

6/ 33.33
16/ 35.56

5/ 27.78
13/ 28.98

5/ 27.78
10/ 22.22

1/ 5.56
6/ 13.33

1/ 5.56
0/ 0

109 mummies tested for 16 HL-A antigens. A ll samples from the pre-Ceramic group, which were the
oldest to be tested , showed positive reactio ns with
one or more of the 16 HL-A antisera employed.
However, 12 of the 38 pre-Columbian Ceramic, 6 of
the 18 Colo nia l Peruvi an, and 16 of t he 45 Colonia l
Ch ilean groups showed none of the 16 antigens for
which they were tested. Thus 31.2% of the mummies
were nonreactive.
The amount of tissue needed to neutralize an
HL-A a ntiserum varied from mummy to mumm y.
Only 6 mg/ ml of antigen from certain mummies
were needed to com pletely inhibit a certa in an tiserum w hile other mummies were able to do so
o nly with the highest concentration of the antigen (24
mg/ ml). None of the powders surrounding mummies produced a positive inhibition test.
The percentage distribution of the HL-A antigens in the 75 positive mummies is given in Table 3.
The reported percentage distribution of these antigens in seven contemporary American Indi an tribes is
given in T able 4 for comparison purposes.

tion since H L-A antigen concentrations on
different body tissues are different). A
mumm y is positive for an antigen when
percentage inhibition is more than 50%.

Results.
ABO TYPI NG
The results of testing the 111 mummies by the
agglutination-inhibition technique are given in Table
1· as a percentage distribution of the ABO groups
among the four groups to which the mummies belo nged . For comparison purposes, we have included
in this table the percentage distributi o n of the A BO
groups in seven contemporary American Indian
groups .
HL-A TYPING
T able 2 shows the number of mummies in each
group that gave positive tests for 0, I , 2, 3 or 4 HL-A
antigens. Positive results for at least o ne histocompatibility antigen were obtained in 75 (68.8% ) of the

Table 3
Frequency in Percent of 16 Antigens in 75 Mummified Pre-Colombian and Colonial T issues Giving at least One
Positive Test
A NTI GENS
F irst Segregant Series
Group

2

HL-A
3

Second Segrega nt Series

w
9

II

19

28

5

7

HL-A
8

w
12

13

5

14

15

17

PRE-COLOM BI AN
Pre-Ceramic
(Huacho)
Ceramic

0

75

0

0

12

62

12

50

0

0

0

50

0

0

0

25

0

69

4

23

0

15

19

23

9

4

0

4

15

0

8

4

COLON I AL
Chilean
Peruvian

0
0

83
58

0
7

8
14

0
0

17
27

8
0

50
52

9
0

9
0

25
7

0
10

0
0

0
0

0

0
0
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Table 4
Frequency in Percent of 16 Antigens in Seven American Indian Tribes, Eskimos, Easter Islanders and Caucasians
ANTIGENS
Second Segregant Series
HL-A

First Segregant Series
w
HL-A
C ultural Group
AMERICAN INDIA NS'
Aymara
Warao
Quechua
I xii
Zuni
Papago
Pima

2
0
2
3
0
0
0

7

8

12

35
58
7
17
16
10
5

0
0
6
0
0
2.7
3

0
0
I
0
0.7

0
0
3
7
0
4

2

3

9

II

19

28

5

74
74
85
66
76
76
68

5
0
I
0
0

0
0

66
42
12

4

24
31
37
30
50
56
67

22
0

5
19
20
38
5
0
0

10

27
I
0

1.3
0

w

5

14

15

17

0
0
I
0
0
0
0

5
4
58
64
50
30
12

0
0
3
3
0
0

56
71
34
3
7
0
0

2
2
I
0 .8
0.7
2.7
0

0.6

40

13

ESKIMOS

2.3

29

2.8

89

4

25

29

3

0

14

EASTER ISLANDERS

0

32

0

69

47

36

0

0

0

0

36

0

0

0

0

0

38

51

27

21

II

13

5

19

32

27

28

4

3

4

7

6

CAUCASIANS'

3.4

Discussion.
There a re several basic types of population studies using genetic markers, one of which makes use of
differences in gene frequencies to assess the relationships between populations and so to trace phylogeny.
It is generally agreed that the use of gene frequencies
for well-defined polymorphic genetic marks provides
the only satisfactory approach to the study of evolutionary relationships between populations. The more
closely related are two populations, the more similar
their gene frequencies are expected to be. The frequencies detailed in this study allow us to make conclusions as to the evolution and possibly the migration of the a ncient Indian tribes.
Determination of the ABO blood groups a nd
H L-A types a nd their distribution in various ethnic
populations have been the subjects of many reports.
However, similar studies on mummified populations
are scarce and they were made on small samples
compared to the number examined in this report.
The presence of the B and A antigens in the
Paracas India ns of the o ldest pre-Columbian Ceramic group has been reported by Boyd .3 However,
as indicated in Table l , with time the pre-Columbian
Indians began toJose the B gene resulting in almost
complete absence of the antigen in the more recent
populations such as the Peruvian and Chilean Colonial descendents of these people. Boyd2 suggested
that the group B mig ht have been eliminated by natural selection . Ea rlier studies from o ur laboratories in
which the mummies were grouped according to geographic area tended to support this postulate, as it
showed a gradual decline in frequency and con-

1.7

comitant increase in the proportion of group O as
one moves south from the provinces of Nazca and
Pisco in the Department of lea in Peru to Chile. 1
In all cultural groups originating in various excavation sites some extracts were reactive. U nexpectedly, 100% of the specimens from the pre-Ceramic
group (the oldest, about 2500 BC) were reactive,
while the more recent Ceramic a nd Colonials showed
varying degrees of nonreactivity. However, this might
have been due to the small sample of the pre-Ceramic
group.
The absence of detecta ble HL-A antigens in
31.2% of the mummies is probably related to denaturation of the antigens, because of poor preservation.
On the other ha nd, it may be partly related to the
failure to use antisera with additional specificities;
another contrib_utory factor is the presence of histocompatibility antigens yet to be discovered. These
factors and homozygosity could be the reasons underlying the detection of less than four a ntigens in
some of the remaining 68.8%.
The reaction of those mummies that showed
more than o ne antigen was in concordance with the
rules of inherita nce of the a ntigens of the first and
second segregant HL-A alleles.7 In other words, at no
time was there inheritance of more than two antigens
of either series of a lleles.
As in the case of ABO, there is a fair similarity in
the frequency of the HL-A antigens in the mummified prehistoric an d in the contemporary American
Indian populations. Like Stastny,8 we found HL-A l,
HL-A3 , HL-A 7, HL-A8, and HL-A 12 either absent
or of low incidence (4% or less) in the pre-Columbian
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mummies. In addition, we found W 14 to be absent in
all mummies tested. This distribution pattern is similar to th at found among contemporary North and
South American Indians as well as in Eskimos. 6 In
contrast, with the exception of W 14, Europeans have
a significantly higher incidence of these antigens. 5 In
fact, some of these antigens, for example, HL-Al and
HL-AS , have been shown to occur almost exclusively
in Europeans. 5 •9 The similarity between pre-Columbian and present-day Indians in contrast to Europeans can also be seen from the relatively higher
incidence of HL-A2, HL-A5, Wl9, and W28 in the
Indian groups compared to Europeans. 5 These results
are also in agreement with those of Stastny.8 Furthermore, like most contemporary American Indians,
HL-Al I was absent in all but 12% of the pre-Ceramic
group . The Huacho group thus has an HL-A 11 distribution similar to that of the I xii Indians in whom the
antigen is present in 10%. In Europeans, the frequency is similar (11%), while it is prevalent among
the Easter Islanders (47% ). Significant dissimilarities
between ancient and contemporary Indians include
the much higher distribution of W 15 among the
Warao, Quechua, and Aymara tribes (34% to 71 % )
than in the mummies in which only 8% had the antigen.6 There were also differences in the distribution
of some antigens between the pre-Ceramic and the
Ceramic and Colonials. HL-Al I, HL-Al3, Wl7,
and W 19 were present in much higher frequency in
the pre-Ceramic than in the Ceramic group. The
frequency of most antigens in the Chilean and
Peruvian Colonials was similar. However, HL-Al2
was significantly higher in Chilean (25%) than in
Peruvian Colonials (7%), while HL-Al3 was absent
in the former, but present in 10% of the latter group .
Unlike Stastny,8 we did not find HL-A9 to be of a
higher frequency in the mummies than in the Europeans.
Summary.

One hundred and eleven mummies were ABO
typed by the antibody absorption test. The mummies
belonged to the pre-Columbian pre-Ceramic, the preColumbian Ceramic, the Colonial Peruvian, and the
Colonial Chilean cultural groups. The frequency of
the A, 8, AB, and O blood groups was found to be
similar to that among contemporary American Indians. Although the 8 and AB groups were found
among early pre-Columbian Indians, the 8 antigen
became almost extinct in the Colonial mummies . The
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group O constituted the majority among all Indians
(pre-Columbians and Colonials). There was suggestive evidence that with time the pre-Columbian Indians began to lose the 8 gene resulting in complete
absence of the antigen in more recent Indian populations . Of the 111 mummies, 109 were typed for 16
HL-A antigens using a modified lymphocytotoxicityinhibition technique. Analogous similarities between
the distribution of several HL-A antigens were found
between the mummies and contemporary American
Indians . HL-A I and HL-A 7 were absent in all mummies and HL-8 and HL-A 11 present in low frequency
only in the Ceramic and pre-Ceramic groups, respectively. Frequencies significantly higher than in Caucasians were found for HL-A2, Wl9, and W28 in all
but the Chilean Colonial mummies. These antigens
are also of relatively high frequency among most
contemporary American Indians .
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